hat
Nandrolone undecanoate premye parèt nan ane 1960 yo byen bonè ak te jwi siksè relativman fò nan tout anpil nan Ewòp. Te konpoze an tou vann kòm Psychobolan nan kèk mache yo, men Nandrolone undecanoate rete mak nan dominan. Sa a esteroyid anabolik te pwouve yo kenbe anpil benefis terapetik epi yo te apwouve pou itilize nan tretman pou maladi osteyopowoz, malnitrisyon ak nenpòt kondisyon jeneral katabolik. Sepandan, malgre yon dosye track ki trè desan nan sekirite, nan Nandrolone undecanoate 1990 la ak tout konpoze Nandrolone endezyèn ta tou dousman disparèt nan mache a.
eng
Nandrolone undecanoate first appeared in the early 1960’s and enjoyed relatively strong success throughout much of Europe. The compound was also sold as Psychobolan in some markets, but Nandrolone undecanoate remained the dominant brand. This anabolic steroid proved to hold numerous therapeutic benefits and was approved for the use in the treatment of osteoporosis, malnutrition and any general catabolic conditions. However, despite a very decent track record of safety, in the 1990’s Nandrolone undecanoate and all Nandrolone Undecanoate compounds would slowly disappear from the market.